It’s a cross sectional observational study conducted in outpatient clinic of OBG, SDMCMS&H, Dharwad between July-December 2012. 200 married women between 20-45 yrs were interviewed with predesigned questionnaire. Effort was made to identify reasons for wide gap between knowledge and practice of contraception. All women knew atleast one method of contraception but 48% were using some sort of contraception. Most known method was female sterilization, least known were injectables and male sterilization. Common method chosen was female sterilization (70.8%). None adopted male sterilization. Reasons for not using contraception were desire to have child (25%), desire for boys (13.4%), worried about side effect (16.3%), opposition from family members (11.5%), felt pregnancy was naturally spaced (11.5%), no specific reasons (10.5%), couldn’t avail contraceptive facilities (5.7%), inconvenient to use (5.7%). Educational and motivational activities from doctors and health workers is needed to promote the use of contraception. [Int J Reprod Contracept Obstet Gynecol 2013; 2(2.000): 172-176
Background: Antiphospholipid antibodies (APLA) are the most important autoimmune cause of recurrent pregnancy loss (RPL). These pregnancies can be saved if diagnosed and treated adequately. This can be achieved by routine screening for APLA in pregnant women with a bad obstetric history (BOH) and unexplained fetal loss. Aims and Objective: To study the association of antiphosholipid antibodies in women with BOH and thus evaluating the usefulness of routine screening of serum antiphosholipid antibodies in patients with unexplained fetal wastage and BOH for better outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.